About SinoPac China CSI Technology 50 ETF

00887 invests in stocks. The fund's major sectors are Electronic Technology, with 50.32% stocks, and Health Technology, with 21.25% of the basket. The assets are mostly located in the Asia region.

00887 top holdings are Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A, occupying 8.15% and 6.22% of the portfolio correspondingly.

00887 assets under management is ‪4.46 B‬ TWD. It's risen 1.86% over the last month.

00887 fund flows account for ‪6.73 B‬ TWD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

No, 00887 doesn't pay dividends to its holders.

00887 expense ratio is 1.02% meaning you'd have to pay 1.02% of your investment to help manage the fund.

00887 follows the CSI All Index - CNY - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

00887 invests in stocks.

00887 price has fallen by −3.07% over the last month, and its yearly performance shows a −28.85% decrease. See more dynamics on 00887 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −4.14% over the last month, showed a −16.68% decrease in three-month performance and has decreased by −29.32% in a year.